Clinical impact of MRSA in a stem cell transplant unit: Analysis before, during and after an MRSA outbreak

Bone Marrow Transplantation

Volumn 39, Issue 10, 2007, Pages 623-629

  Shaw, B E ^a   Boswell, T ^a   Byrne, J L ^a   Yates, C ^a   Russell, N H ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; BUSULFAN; CARMUSTINE; CHLORHEXIDINE; CHLORHEXIDINE PLUS NEOMYCIN; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; LINEZOLID; MELPHALAN; METICILLIN; NASEPTIN; NEOMYCIN; OXACILLIN; PENICILLIN G; PIPTAZOBACTAM; TRICLOSAN; UNCLASSIFIED DRUG; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTEREMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DEATH; DONOR; DRUG HYPERSENSITIVITY; ENDEMIC DISEASE; EPIDEMIC; ERADICATION THERAPY; FEMALE; HODGKIN DISEASE; HOSPITAL DISCHARGE; HUMAN; HYPEREOSINOPHILIC SYNDROME; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MYELODYSPLASTIC SYNDROME; MYELOMA; NEUROBLASTOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SCREENING TEST; SEPSIS; SIBLING; STAPHYLOCOCCUS INFECTION; WHOLE BODY RADIATION;

ADULT; AGED; BACTEREMIA; DISEASE OUTBREAKS; FEMALE; GREAT BRITAIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34248168812     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705654     Document Type: Article

References (21)

1. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003; 9: 1179-1186.
2. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-1444.
3. Bronzwaer SL, Buchholz U, Kool JL. International surveillance of antimicrobial resistance in Europe: Now we also need to monitor antibiotic use. Euro Surveill 2001; 6: 1-2.
4. Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood 2000; 96: 2419-2425.
5. Matsubara H, Makimoto A, Higa T, Kawamoto H, Kanda Y, Kami M et al. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient. Bone Marrow Transplant 2003; 31: 65-67.
6. Kato N, Tanaka J, Mori A, Tutumi Y, Yonezumi M, Chiba K et al. The risk of persistent carriage of methicillin-resistant Staphylococcus aureus in hematopoietic stem cell transplantation. Ann Hematol 2003; 82: 310-312.
7. Imataki O, Makimoto A, Kato S, Bannai T, Numa N, Nukui Y et al. Coincidental outbreak of methicillin-resistant Staphylococcus aureus in a hematopoietic stem cell transplantation unit. Am J Hematol 2006; 81: 664-669.
8. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000; 6: 659-713; 715; 717-727; quiz 729-733.
9. Bertz H, Auner HW, Weissinger F, Salwender HJ, Einsele H, Egerer G et al. Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82 (Suppl 2): S167-S174.
10. Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63 (Suppl 1): S1-S44.
11. Muller AA, Mauny F, Bertin M, Cornette C, Lopez-Lozano JM, Viel JF et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 2003; 36: 971-978.
12. Hori S, Sunley R, Tami A, Grundmann H. The Nottingham Staphylococcus aureus population study: Prevalence of MRSA among the elderly in a university hospital. J Hosp Infect 2002; 50: 25-29.
13. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000; 31: 1380-1385.
14. Fujita S, Senda Y, Iwagami T, Hashimoto T. Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J Clin Microbiol 2005; 43: 1149-1157.
15. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005; 52: 113-122.
16. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174.
17. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): Systematic review of the literature. BMJ 2004; 329: 533.
18. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: Prospective two-centre study. Lancet 2005; 365: 295-304.
19. Barakate MS, Yang YX, Foo SH, Vickery AM, Sharp CA, Fowler LD et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000; 44: 19-26.
20. Anstead GM, Owens AD. Recent advances in the treatment of infections due to resistant Staphylococcus aureus. Curr Opin Infect Dis 2004; 17: 549-555.
21. Patti JM. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine 2004; 22 (Suppl 1): S39-S43.